APA aipamena

Novik, A. V., Yaremenko, E. V., Anokhina, E. M., Nehaeva, T. L., Semenova, A. I., Latipova, D. K., . . . Baldueva, I. A. (2019). RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences.

Chicago Style aipamena

Novik, A. V., E. V. Yaremenko, E. M. Anokhina, T. L. Nehaeva, A. I. Semenova, D. Kh Latipova, S. A. Protsenko, and I. A. Baldueva. RECIST 1.1 AND IrRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences, 2019.

MLA aipamena

Novik, A. V., et al. RECIST 1.1 AND IrRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences, 2019.